Introduction
Oxcarbazepine is an anticonvulsant medication used primarily for the treatment of epilepsy and certain types of seizures. It is structurally related to carbamazepine and is known for its efficacy in managing partial seizures.
Uses
Oxcarbazepine is used for:
- Treatment of partial seizures, including those that may become secondary generalized seizures.
- As adjunctive therapy for adults and children with epilepsy who have not achieved adequate control with other medications.
- Off-label, it may be used for bipolar disorder and neuropathic pain, though this is less common and depends on individual clinical circumstances.
| Brand Name | Oxcarbazepine |
|---|---|
| Type | |
| Weight | |
| Generic | Oxcarbazepine |
| Manufacturer | |
| Available in | English বাংলা |
Mechanism of Action
Oxcarbazepine works by stabilizing hyperexcitable neuronal membranes and inhibiting abnormal neuronal discharge. It is believed to exert its anticonvulsant effects through the modulation of voltage-gated sodium channels, reducing neuronal excitability. Unlike carbamazepine, oxcarbazepine is a prodrug that is converted into its active metabolite, licarbazepine, which is responsible for its therapeutic effects.
How Long Does It Take to Work?
Patients may start to see improvements in seizure control within 1-2 weeks of starting oxcarbazepine therapy. However, optimal therapeutic effects may take several weeks to be fully realized, and dose adjustments may be necessary based on individual response and tolerability.
Absorption
Oxcarbazepine is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations typically reached within 4-6 hours after oral administration. The bioavailability of oxcarbazepine is approximately 95% when taken orally.
Route of Elimination
Oxcarbazepine is primarily metabolized in the liver to its active metabolite, licarbazepine. The drug and its metabolites are excreted mainly through the kidneys, with around 70% of the dose eliminated in the urine and the remainder in the feces.
Dosage
Adults: initiate with a dose of 600 mg/day, given twice-a-day- Adjunctive Therapy: Maximum increment of 600 mg/day at approximately weekly intervals. The recommended daily dose is 1200 mg/day
- Conversion to Monotherapy: withdrawal concomitant over 3 to 6 weeks;reach maximum dose of Oxcarbazepine in 2 to 4 weeks with increments of 600 mg/day at weekly intervals to a recommended daily dose of 2400 mg/day
- Initiation of Monotherapy: Increments of 300 mg/day every third day to a dose of 1200 mg/day.
- Creatinine Clearance <30 mL/min: Initiate at one half the usual starting dose and increase slowly
- Adjunctive Patients (Aged 2–16 Years): For patients aged 4 to 16 years, target maintenance dose should be achieved over 2 weeks. For patients aged 2 to <4 years, maximum maintenance dose should be achieved over 2 to 4 weeks and should not to exceed 60 mg/kg/day
- Conversion to Monotherapy for Patients (Aged 4-16 Years): Maximum increment of 10 mg/kg/day at weekly intervals, concomitant antiepileptic drugs can be completely withdrawn over 3 to 6 weeks
- Initiation of Monotherapy for Patients (Aged 4–16 Years): Increments of 5 mg/kg/day every third day
Dosage varies based on age, weight, and clinical condition:
- Adults: The typical starting dose is 300 mg twice daily, which can be increased by 300 mg every week to a usual dose range of 600-1,200 mg per day in divided doses. Maximum daily dose is 1,200 mg.
- Children: Starting doses are generally lower, and the dose is adjusted based on body weight and clinical response. Dosage ranges from 8 to 10 mg/kg/day, typically administered in two to three divided doses.
Administration
Oxcarbazepine is administered orally, available in tablet and oral suspension forms. Tablets should be swallowed whole, while the oral suspension should be shaken well before use. It can be taken with or without food.
Side Effects
Common side effects include:
- Dizziness.
- Somnolence (sleepiness).
- Headache.
- Gastrointestinal symptoms such as nausea and vomiting.
- Fatigue and ataxia (lack of muscle coordination).
- Severe allergic reactions.
- Hyponatremia (low sodium levels in the blood).
- Hematological abnormalities like leukopenia (low white blood cell count).
Toxicity
Symptoms of overdose or toxicity may include severe drowsiness, agitation, confusion, and seizures. Treatment involves supportive care, and activated charcoal may be used to limit further absorption if overdose is recent. Monitoring and supportive care in a medical setting are recommended.
Precautions
Precautions include:
- Regular monitoring of blood sodium levels due to the risk of hyponatremia.
- Assessing liver and kidney function periodically.
- Monitoring for signs of suicidal thoughts or behavior, as with other anticonvulsants.
Interaction
Oxcarbazepine may interact with other medications, including:
- Oral contraceptives, which may require dose adjustments due to potential reduced effectiveness.
- Other antiepileptic drugs, which may affect oxcarbazepine levels and vice versa.
Disease Interaction
Use with caution in patients with:
- Kidney impairment, as oxcarbazepine and its metabolites are excreted via the kidneys.
- Liver dysfunction, as it may affect the metabolism of oxcarbazepine.
Drug Interaction
Potential drug interactions include:
- Enzyme inducers (e.g., rifampin) which may decrease oxcarbazepine levels.
- Enzyme inhibitors (e.g., ketoconazole) which may increase oxcarbazepine levels.
Food Interactions
Food does not significantly affect the absorption of oxcarbazepine. However, maintaining a consistent diet is advisable to avoid fluctuations in drug levels.
Pregnancy Use
Oxcarbazepine is classified as Category C for pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus. Adequate contraception should be used to prevent pregnancy during treatment.
Lactation Use
Oxcarbazepine is excreted in breast milk. The risk to the nursing infant is not well studied, so breastfeeding may be discouraged or monitored closely if the drug is used.
Acute Overdose
In case of acute overdose, symptoms may include drowsiness, confusion, and in severe cases, seizures. Treatment focuses on supportive care, monitoring, and possibly using activated charcoal if ingestion was recent.
Contraindication
Oxcarbazepine is contraindicated in patients with a history of hypersensitivity to oxcarbazepine or other carbamazepine derivatives. Caution is advised in patients with significant renal or hepatic impairment.
Use Direction
Take oxcarbazepine exactly as prescribed by your healthcare provider. Regular follow-up appointments are essential to monitor response and adjust dosage if needed. Do not abruptly stop the medication without medical advice, as this may increase seizure frequency.
Storage Conditions
Store oxcarbazepine tablets and oral suspension at room temperature, away from moisture and heat. Keep the medication out of reach of children.
Volume of Distribution
The volume of distribution for oxcarbazepine is approximately 0.4 L/kg, reflecting its distribution in body tissues.
Half Life
The terminal half-life of oxcarbazepine is approximately 9-10 hours, which supports the need for dosing every 12 hours for most patients.
Clearance
Oxcarbazepine is primarily cleared through renal excretion of its metabolites. The clearance rate may be reduced in patients with renal impairment, necessitating dose adjustments.
See in details version Oxcarbazepine also Oxcarbazepine in bangla
